BioLife Solutions (BLFS) CMO has 293 shares withheld to cover RSU taxes

Rhea-AI Filing Summary

BioLife Solutions Inc Chief Marketing Officer Todd Berard reported a tax-withholding disposition of 293 shares of Common Stock on 2026-07-07. The issuer withheld these shares to satisfy Berard’s tax obligations upon the release of restricted stock units at $27.79 per share, leaving him with 162,649 shares owned directly.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Berard Todd

Role Chief Marketing Officer

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock	293	$27.79	$8K

Holdings After Transaction: Common Stock — 162,649 shares (Direct)

Footnotes (1)

1. [object Object]

Key Figures

Shares withheld for taxes: 293 shares Price per share for withholding: $27.79 Shares owned after transaction: 162,649 shares +1 more

4 metrics

Shares withheld for taxes 293 shares Common Stock withheld on 2026-07-07 to satisfy tax obligations on restricted stock unit release

Price per share for withholding $27.79 Value per share used for the 293-share tax-withholding disposition reported by Todd Berard

Shares owned after transaction 162,649 shares Total BioLife Solutions Common Stock directly owned by Todd Berard following the tax-withholding disposition

Tax-withholding shares in summary 293 shares transactionSummary shows 293 shares involved in tax withholding dispositions

Key Terms

restricted stock units, tax withholding obligations, Payment of exercise price or tax liability by delivering securities

3 terms

restricted stock units financial

"arose upon the release of restricted stock units"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

tax withholding obligations financial

"to satisfy tax withholding obligations of the reporting person"

Payment of exercise price or tax liability by delivering securities financial

"transaction_code_description: Payment of exercise price or tax liability by delivering securities"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/13/2026 - 05:03 PM Accepted by SEC EDGAR 07/13/2026 - 05:03 PM Learn about SEC filing dates

FAQ

What insider transaction did BLFS Chief Marketing Officer Todd Berard report?

Todd Berard reported a tax-withholding disposition of 293 shares of BioLife Solutions Common Stock. The issuer withheld these shares to cover taxes triggered by the release of restricted stock units, rather than through an open-market sale.

How many BLFS shares were withheld for Todd Berard’s taxes and at what price?

The issuer withheld 293 shares of BioLife Solutions (BLFS) Common Stock at $27.79 per share. This tax-withholding disposition arose from the release of restricted stock units credited to Berard.

Did Todd Berard make an open-market sale of BLFS stock in this Form 4?

No, the Form 4 shows a tax-withholding disposition, not an open-market sale. Shares were withheld by BioLife Solutions to satisfy Berard’s tax liabilities when his restricted stock units were released.

How many BLFS shares does Todd Berard own after this reported transaction?

After the tax-withholding disposition, Todd Berard directly owns 162,649 shares of BioLife Solutions Common Stock. This figure reflects his holdings following the issuer’s withholding of 293 shares for tax obligations.

What is the transaction code used in Todd Berard’s BLFS Form 4 filing?

The transaction is coded F, meaning “Payment of exercise price or tax liability by delivering securities.” Here, it reflects shares withheld by BioLife Solutions to cover Todd Berard’s tax obligations on restricted stock unit release.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Berard Todd

(Last) (First) (Middle)

3303 MONTE VILLA PARKWAY

SUITE 310

(Street)

BOTHELL WASHINGTON 98021

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
BIOLIFE SOLUTIONS INC [ BLFS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Marketing Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/07/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/07/2026		F		293(1)	D	$27.79	162,649	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units.

Remarks:

	/s/ Todd Berard	07/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)